Ghana

Ghana

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
9.07 (8.28 - 9.92) 2019 Modelled IHME
9.08 (8.32 - 9.78) 2018 Modelled IHME
9.11 (8.32 - 9.92) 2017 Modelled IHME
9.68 (8.87 - 10.41) 2016 Modelled IHME
10.47 (9.55 - 11.30) 2015 Modelled IHME
10.9 (9.98 - 11.72) 2014 Modelled IHME
11.25 (10.26 - 12.09) 2013 Modelled IHME
11.56 (10.54 - 12.46) 2012 Modelled IHME
11.86 (10.78 - 12.87) 2011 Modelled IHME
12.19 (11.06 - 13.29) 2010 Modelled IHME
12.56 (11.43 - 13.64) 2009 Modelled IHME
12.94 (11.82 - 14.01) 2008 Modelled IHME
13.33 (12.20 - 14.40) 2007 Modelled IHME
13.72 (12.53 - 14.87) 2006 Modelled IHME
14.09 (12.87 - 15.29) 2005 Modelled IHME
14.49 (13.26 - 15.69) 2004 Modelled IHME
14.92 (13.62 - 16.12) 2003 Modelled IHME
15.33 (14.03 - 16.56) 2002 Modelled IHME
15.67 (14.31 - 16.99) 2001 Modelled IHME
15.9 (14.52 - 17.28) 2000 Modelled IHME
16.04 (14.74 - 17.43) 1999 Modelled IHME
16.15 (14.89 - 17.51) 1998 Modelled IHME
16.23 (14.96 - 17.59) 1997 Modelled IHME
16.32 (15.07 - 17.72) 1996 Modelled IHME
16.42 (15.12 - 17.87) 1995 Modelled IHME
16.54 (15.27 - 17.98) 1994 Modelled IHME
16.66 (15.41 - 18.06) 1993 Modelled IHME
16.79 (15.53 - 18.16) 1992 Modelled IHME
16.92 (15.62 - 18.31) 1991 Modelled IHME
17.06 (15.73 - 18.50) 1990 Modelled IHME
8.63 (7.19 - 10.34) 2015 Modelled WHO
12.92 (12.44 - 13.42) 2013 Modelled Schweitzer et al, 2015
12.3 (11.30 - 13.40) 2015 Modelled Ofori-Asenso and Agyeman, 2016
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.64 (0.50 - 0.80) 2019 Modelled IHME
0.66 (0.52 - 0.81) 2018 Modelled IHME
0.71 (0.55 - 0.87) 2017 Modelled IHME
0.94 (0.75 - 1.15) 2016 Modelled IHME
1.25 (1 - 1.55) 2015 Modelled IHME
1.45 (1.18 - 1.79) 2014 Modelled IHME
1.64 (1.35 - 2.01) 2013 Modelled IHME
1.8 (1.49 - 2.21) 2012 Modelled IHME
1.94 (1.60 - 2.39) 2011 Modelled IHME
2.06 (1.69 - 2.53) 2010 Modelled IHME
2.14 (1.77 - 2.59) 2009 Modelled IHME
2.2 (1.82 - 2.64) 2008 Modelled IHME
2.25 (1.86 - 2.70) 2007 Modelled IHME
2.33 (1.92 - 2.80) 2006 Modelled IHME
2.45 (1.99 - 2.96) 2005 Modelled IHME
3.46 (2.86 - 4.19) 2004 Modelled IHME
5.68 (4.71 - 6.86) 2003 Modelled IHME
8.32 (6.88 - 10.02) 2002 Modelled IHME
10.59 (8.70 - 12.80) 2001 Modelled IHME
11.7 (9.57 - 14.22) 2000 Modelled IHME
11.93 (9.72 - 14.40) 1999 Modelled IHME
12.09 (9.88 - 14.55) 1998 Modelled IHME
12.21 (9.92 - 14.55) 1997 Modelled IHME
12.31 (9.93 - 14.65) 1996 Modelled IHME
12.42 (9.99 - 14.79) 1995 Modelled IHME
12.55 (10.16 - 15.01) 1994 Modelled IHME
12.68 (10.34 - 15.09) 1993 Modelled IHME
12.81 (10.50 - 15.20) 1992 Modelled IHME
12.93 (10.65 - 15.26) 1991 Modelled IHME
13.05 (10.80 - 15.37) 1990 Modelled IHME
3.61 (2.50 - 5) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.89 (7.21 - 13.20) 2019 Modelled IHME
9.95 (7.38 - 13.30) 2018 Modelled IHME
10.2 (7.60 - 13.40) 2017 Modelled IHME
10.1 (7.64 - 13.10) 2016 Modelled IHME
10.1 (7.74 - 12.90) 2015 Modelled IHME
10.5 (8.15 - 13.20) 2014 Modelled IHME
11.1 (8.63 - 13.80) 2013 Modelled IHME
11.8 (9.24 - 14.60) 2012 Modelled IHME
12.4 (9.71 - 15.10) 2011 Modelled IHME
12.7 (9.93 - 15.50) 2010 Modelled IHME
12.8 (10.10 - 15.60) 2009 Modelled IHME
13.1 (10.30 - 16) 2008 Modelled IHME
13.4 (10.60 - 16.40) 2007 Modelled IHME
13.7 (10.90 - 16.70) 2006 Modelled IHME
14 (11 - 17) 2005 Modelled IHME
14.2 (11.10 - 17.30) 2004 Modelled IHME
14.5 (11.30 - 17.80) 2003 Modelled IHME
15 (11.70 - 18.40) 2002 Modelled IHME
15.3 (12.10 - 18.90) 2001 Modelled IHME
15.6 (12.10 - 19.60) 2000 Modelled IHME
15.8 (12.20 - 20.30) 1999 Modelled IHME
15.9 (12.10 - 20.90) 1998 Modelled IHME
16.1 (12 - 21.30) 1997 Modelled IHME
15.9 (11.80 - 21.60) 1996 Modelled IHME
15.9 (11.70 - 21.70) 1995 Modelled IHME
15.9 (11.60 - 21.90) 1994 Modelled IHME
15.9 (11.50 - 22.10) 1993 Modelled IHME
15.8 (11.30 - 22.20) 1992 Modelled IHME
15.7 (11.10 - 22.10) 1991 Modelled IHME
15.6 (11 - 21.90) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,118 (2,273 - 4,155) 2019 Modelled IHME
3,069 (2,274 - 4,098) 2018 Modelled IHME
3,065 (2,289 - 4,036) 2017 Modelled IHME
2,975 (2,249 - 3,861) 2016 Modelled IHME
2,913 (2,224 - 3,718) 2015 Modelled IHME
2,943 (2,286 - 3,706) 2014 Modelled IHME
3,030 (2,360 - 3,775) 2013 Modelled IHME
3,148 (2,463 - 3,888) 2012 Modelled IHME
3,228 (2,522 - 3,929) 2011 Modelled IHME
3,217 (2,512 - 3,924) 2010 Modelled IHME
3,162 (2,487 - 3,842) 2009 Modelled IHME
3,127 (2,464 - 3,826) 2008 Modelled IHME
3,113 (2,469 - 3,814) 2007 Modelled IHME
3,093 (2,459 - 3,788) 2006 Modelled IHME
3,074 (2,427 - 3,748) 2005 Modelled IHME
3,034 (2,382 - 3,705) 2004 Modelled IHME
3,022 (2,362 - 3,707) 2003 Modelled IHME
3,029 (2,375 - 3,723) 2002 Modelled IHME
3,021 (2,384 - 3,726) 2001 Modelled IHME
2,986 (2,320 - 3,755) 2000 Modelled IHME
2,949 (2,278 - 3,785) 1999 Modelled IHME
2,903 (2,201 - 3,801) 1998 Modelled IHME
2,851 (2,130 - 3,778) 1997 Modelled IHME
2,749 (2,041 - 3,734) 1996 Modelled IHME
2,680 (1,972 - 3,666) 1995 Modelled IHME
2,629 (1,921 - 3,615) 1994 Modelled IHME
2,569 (1,853 - 3,559) 1993 Modelled IHME
2,490 (1,774 - 3,486) 1992 Modelled IHME
2,408 (1,706 - 3,405) 1991 Modelled IHME
2,339 (1,653 - 3,291) 1990 Modelled IHME
5,108 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
51 (42 - 60) 2019 Modelled IHME
51 (42 - 60) 2018 Modelled IHME
51 (42 - 60) 2017 Modelled IHME
51 (42 - 60) 2016 Modelled IHME
51 (42 - 59) 2015 Modelled IHME
51 (42 - 60) 2014 Modelled IHME
51 (43 - 60) 2013 Modelled IHME
52 (43 - 61) 2012 Modelled IHME
52 (44 - 61) 2011 Modelled IHME
52 (44 - 61) 2010 Modelled IHME
52 (44 - 61) 2009 Modelled IHME
52 (44 - 61) 2008 Modelled IHME
52 (44 - 61) 2007 Modelled IHME
52 (44 - 61) 2006 Modelled IHME
52 (44 - 61) 2005 Modelled IHME
52 (44 - 61) 2004 Modelled IHME
53 (44 - 61) 2003 Modelled IHME
53 (45 - 61) 2002 Modelled IHME
54 (45 - 62) 2001 Modelled IHME
54 (45 - 62) 2000 Modelled IHME
54 (45 - 62) 1999 Modelled IHME
54 (45 - 62) 1998 Modelled IHME
54 (45 - 62) 1997 Modelled IHME
53 (45 - 62) 1996 Modelled IHME
53 (44 - 62) 1995 Modelled IHME
53 (44 - 62) 1994 Modelled IHME
53 (44 - 62) 1993 Modelled IHME
53 (44 - 62) 1992 Modelled IHME
53 (44 - 62) 1991 Modelled IHME
53 (44 - 62) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
90 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
94 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
84 2006 Survey/reported WHO/UNICEF
84 2005 Survey/reported WHO/UNICEF
80 2004 Survey/reported WHO/UNICEF
80 2003 Survey/reported WHO/UNICEF
80 2002 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
Risk-based
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3.33 (2.65 - 4.20) 2019 Modelled IHME
3.33 (2.67 - 4.20) 2018 Modelled IHME
3.34 (2.67 - 4.22) 2017 Modelled IHME
3.35 (2.69 - 4.20) 2016 Modelled IHME
3.36 (2.69 - 4.20) 2015 Modelled IHME
3.38 (2.70 - 4.22) 2014 Modelled IHME
3.42 (2.73 - 4.28) 2013 Modelled IHME
3.47 (2.78 - 4.34) 2012 Modelled IHME
3.52 (2.83 - 4.40) 2011 Modelled IHME
3.56 (2.87 - 4.48) 2010 Modelled IHME
3.6 (2.91 - 4.49) 2009 Modelled IHME
3.64 (2.94 - 4.53) 2008 Modelled IHME
3.68 (2.99 - 4.57) 2007 Modelled IHME
3.73 (3.02 - 4.57) 2006 Modelled IHME
3.79 (3.04 - 4.62) 2005 Modelled IHME
3.87 (3.14 - 4.68) 2004 Modelled IHME
3.97 (3.27 - 4.74) 2003 Modelled IHME
4.09 (3.39 - 4.84) 2002 Modelled IHME
4.19 (3.50 - 4.95) 2001 Modelled IHME
4.27 (3.56 - 5.04) 2000 Modelled IHME
4.32 (3.60 - 5.11) 1999 Modelled IHME
4.38 (3.63 - 5.18) 1998 Modelled IHME
4.43 (3.66 - 5.24) 1997 Modelled IHME
4.46 (3.67 - 5.31) 1996 Modelled IHME
4.47 (3.67 - 5.33) 1995 Modelled IHME
4.47 (3.68 - 5.31) 1994 Modelled IHME
4.47 (3.66 - 5.30) 1993 Modelled IHME
4.46 (3.64 - 5.33) 1992 Modelled IHME
4.44 (3.61 - 5.32) 1991 Modelled IHME
4.42 (3.57 - 5.34) 1990 Modelled IHME
1.4 (1.10 - 3.40) 2015 Modelled Blach et al, 2017
1.5 (0.90 - 4.10) 2015 Modelled Maaroufi et al, 2017
1.4 (1.10 - 3.40) 2017 Modelled Sonderup et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.2 (0.50 - 8.10) 2014 Modelled Riou et al, 2015
2 (1.20 - 5.50) 2014 Modelled Maaroufi et al, 2017
3 (2.60 - 3.50) 2015 Modelled Agyeman et al, 2016
3.2 (0.50 - 8.10) 2017 Modelled Sonderup et al, 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
40.1 (34.80 - 45.40) 2005 Survey/reported Adjei A et al, 2007

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.75 (1.23 - 2.42) 2019 Modelled IHME
1.78 (1.24 - 2.46) 2018 Modelled IHME
1.82 (1.29 - 2.53) 2017 Modelled IHME
1.8 (1.27 - 2.48) 2016 Modelled IHME
1.79 (1.27 - 2.43) 2015 Modelled IHME
1.78 (1.27 - 2.43) 2014 Modelled IHME
1.76 (1.27 - 2.37) 2013 Modelled IHME
1.74 (1.25 - 2.36) 2012 Modelled IHME
1.74 (1.25 - 2.35) 2011 Modelled IHME
1.74 (1.26 - 2.35) 2010 Modelled IHME
1.76 (1.27 - 2.36) 2009 Modelled IHME
1.78 (1.29 - 2.41) 2008 Modelled IHME
1.81 (1.31 - 2.44) 2007 Modelled IHME
1.85 (1.35 - 2.51) 2006 Modelled IHME
1.9 (1.39 - 2.57) 2005 Modelled IHME
1.94 (1.42 - 2.63) 2004 Modelled IHME
1.99 (1.45 - 2.70) 2003 Modelled IHME
2.05 (1.50 - 2.78) 2002 Modelled IHME
2.1 (1.53 - 2.85) 2001 Modelled IHME
2.15 (1.56 - 2.92) 2000 Modelled IHME
2.17 (1.56 - 2.95) 1999 Modelled IHME
2.18 (1.55 - 2.96) 1998 Modelled IHME
2.21 (1.54 - 3.02) 1997 Modelled IHME
2.19 (1.50 - 3.06) 1996 Modelled IHME
2.19 (1.49 - 3.08) 1995 Modelled IHME
2.2 (1.50 - 3.12) 1994 Modelled IHME
2.21 (1.49 - 3.12) 1993 Modelled IHME
2.23 (1.50 - 3.16) 1992 Modelled IHME
2.24 (1.50 - 3.19) 1991 Modelled IHME
2.25 (1.49 - 3.24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
552 (387 - 764) 2019 Modelled IHME
548 (384 - 758) 2018 Modelled IHME
548 (388 - 762) 2017 Modelled IHME
529 (375 - 731) 2016 Modelled IHME
513 (364 - 699) 2015 Modelled IHME
500 (358 - 681) 2014 Modelled IHME
481 (347 - 647) 2013 Modelled IHME
465 (333 - 631) 2012 Modelled IHME
451 (324 - 610) 2011 Modelled IHME
441 (318 - 595) 2010 Modelled IHME
433 (312 - 580) 2009 Modelled IHME
426 (308 - 577) 2008 Modelled IHME
421 (304 - 569) 2007 Modelled IHME
419 (306 - 568) 2006 Modelled IHME
419 (306 - 566) 2005 Modelled IHME
416 (305 - 562) 2004 Modelled IHME
414 (302 - 563) 2003 Modelled IHME
414 (303 - 563) 2002 Modelled IHME
413 (302 - 562) 2001 Modelled IHME
412 (298 - 560) 2000 Modelled IHME
405 (292 - 551) 1999 Modelled IHME
398 (282 - 540) 1998 Modelled IHME
392 (273 - 536) 1997 Modelled IHME
379 (259 - 530) 1996 Modelled IHME
370 (253 - 521) 1995 Modelled IHME
363 (247 - 514) 1994 Modelled IHME
357 (240 - 503) 1993 Modelled IHME
351 (235 - 497) 1992 Modelled IHME
344 (230 - 490) 1991 Modelled IHME
338 (223 - 487) 1990 Modelled IHME
1,090 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
14 (9 - 19) 2019 Modelled IHME
14 (9 - 19) 2018 Modelled IHME
14 (9 - 19) 2017 Modelled IHME
14 (9 - 19) 2016 Modelled IHME
14 (10 - 19) 2015 Modelled IHME
14 (10 - 19) 2014 Modelled IHME
14 (10 - 19) 2013 Modelled IHME
14 (10 - 19) 2012 Modelled IHME
14 (10 - 19) 2011 Modelled IHME
14 (10 - 20) 2010 Modelled IHME
14 (10 - 20) 2009 Modelled IHME
14 (10 - 20) 2008 Modelled IHME
14 (10 - 20) 2007 Modelled IHME
14 (10 - 20) 2006 Modelled IHME
14 (10 - 20) 2005 Modelled IHME
14 (10 - 20) 2004 Modelled IHME
14 (10 - 19) 2003 Modelled IHME
14 (10 - 19) 2002 Modelled IHME
14 (9 - 19) 2001 Modelled IHME
14 (10 - 19) 2000 Modelled IHME
14 (10 - 19) 1999 Modelled IHME
14 (10 - 19) 1998 Modelled IHME
14 (10 - 20) 1997 Modelled IHME
15 (10 - 20) 1996 Modelled IHME
15 (10 - 20) 1995 Modelled IHME
15 (10 - 20) 1994 Modelled IHME
15 (10 - 20) 1993 Modelled IHME
15 (10 - 20) 1992 Modelled IHME
15 (10 - 20) 1991 Modelled IHME
15 (10 - 21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
Risk-based
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3,118
2019
(2,273 - 4,155)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
552
2019
(387 - 764)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines